Maria L.H. Vlaming

1.8k total citations
30 papers, 1.4k citations indexed

About

Maria L.H. Vlaming is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Maria L.H. Vlaming has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Pediatrics, Perinatology and Child Health and 5 papers in Infectious Diseases. Recurrent topics in Maria L.H. Vlaming's work include Drug Transport and Resistance Mechanisms (21 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Trace Elements in Health (5 papers). Maria L.H. Vlaming is often cited by papers focused on Drug Transport and Resistance Mechanisms (21 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Trace Elements in Health (5 papers). Maria L.H. Vlaming collaborates with scholars based in Netherlands, Belgium and Türkiye. Maria L.H. Vlaming's co-authors include Alfred H. Schinkel, Jurjen S. Lagas, Els Wagenaar, Olaf van Tellingen, Jos H. Beijnen, Dirk R. de Waart, Jean‐Marc Fritschy, Ronald P.J. Oude Elferink, Koen van de Wetering and Anita van Esch and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Cancer Research and Neuroscience.

In The Last Decade

Maria L.H. Vlaming

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria L.H. Vlaming Netherlands 21 994 479 328 272 191 30 1.4k
Kathleen Köck United States 21 991 1.0× 427 0.9× 311 0.9× 358 1.3× 187 1.0× 28 1.5k
Sierk Haenisch Germany 23 829 0.8× 491 1.0× 440 1.3× 242 0.9× 171 0.9× 30 1.4k
Pauline Breedveld Netherlands 8 778 0.8× 374 0.8× 269 0.8× 149 0.5× 99 0.5× 9 1.1k
Yoshitane Nozaki Japan 16 902 0.9× 497 1.0× 193 0.6× 336 1.2× 78 0.4× 26 1.3k
Maya K. Leabman United States 16 1.2k 1.2× 442 0.9× 675 2.1× 195 0.7× 212 1.1× 33 2.0k
Kelly Bleasby United States 16 674 0.7× 349 0.7× 240 0.7× 236 0.9× 114 0.6× 21 1.1k
Janny G.P. Peters Netherlands 18 533 0.5× 326 0.7× 552 1.7× 117 0.4× 168 0.9× 23 1.3k
Cornelia M.M. van der Kruijssen Netherlands 14 647 0.7× 295 0.6× 315 1.0× 375 1.4× 107 0.6× 17 1.0k
Marie V. St–Pierre Switzerland 24 987 1.0× 489 1.0× 552 1.7× 185 0.7× 284 1.5× 43 1.9k
Cindy Q. Xia United States 20 777 0.8× 307 0.6× 481 1.5× 281 1.0× 62 0.3× 47 1.4k

Countries citing papers authored by Maria L.H. Vlaming

Since Specialization
Citations

This map shows the geographic impact of Maria L.H. Vlaming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria L.H. Vlaming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria L.H. Vlaming more than expected).

Fields of papers citing papers by Maria L.H. Vlaming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria L.H. Vlaming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria L.H. Vlaming. The network helps show where Maria L.H. Vlaming may publish in the future.

Co-authorship network of co-authors of Maria L.H. Vlaming

This figure shows the co-authorship network connecting the top 25 collaborators of Maria L.H. Vlaming. A scholar is included among the top collaborators of Maria L.H. Vlaming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria L.H. Vlaming. Maria L.H. Vlaming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mannhardt, Ingra, Umber Saleem, Diogo Mosqueira, et al.. (2020). Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format. Stem Cell Reports. 15(4). 983–998. 44 indexed citations
2.
Steeg, Evita van de, et al.. (2017). Feasibility of SPECT-CT Imaging to Study the Pharmacokinetics of Antisense Oligonucleotides in a Mouse Model of Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 27(4). 221–231. 1 indexed citations
3.
Steeg, Evita van de, et al.. (2015). Generation of Bayesian prediction models for OATP-mediated drug–drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3. European Journal of Pharmaceutical Sciences. 70. 29–36. 15 indexed citations
4.
Bosgra, Sieto, Evita van de Steeg, Maria L.H. Vlaming, et al.. (2014). Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling. European Journal of Pharmaceutical Sciences. 65. 156–166. 63 indexed citations
5.
Vlaming, Maria L.H., Sebastiaan F. Teunissen, Evita van de Steeg, et al.. (2013). Bcrp1;Mdr1a/b;Mrp2 Combination Knockout Mice: Altered Disposition of the Dietary Carcinogen PhIP (2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine) and Its Genotoxic Metabolites. Molecular Pharmacology. 85(3). 520–530. 21 indexed citations
6.
Steeg, Evita van de, Rick Greupink, Kitty Verhoeckx, et al.. (2012). Drug-Drug Interactions between Rosuvastatin and Oral Antidiabetic Drugs Occurring at the Level of OATP1B1. Drug Metabolism and Disposition. 41(3). 592–601. 49 indexed citations
7.
Läppchen, Tilman, Maria L.H. Vlaming, Johan Lub, et al.. (2011). Automated synthesis of [18F]gefitinib on a modular system. Applied Radiation and Isotopes. 70(1). 205–209. 16 indexed citations
8.
Waart, Dirk R. de, Stéphanie Häusler, Maria L.H. Vlaming, et al.. (2010). Hepatic Transport Mechanisms of Cholyl-l-Lysyl-Fluorescein. Journal of Pharmacology and Experimental Therapeutics. 334(1). 78–86. 74 indexed citations
9.
10.
Vlaming, Maria L.H., Anita van Esch, Els Wagenaar, et al.. (2009). Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo. Clinical Cancer Research. 15(9). 3084–3093. 72 indexed citations
11.
Lagas, Jurjen S., Fan Lin, Els Wagenaar, et al.. (2009). P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide. Clinical Cancer Research. 16(1). 130–140. 72 indexed citations
12.
Vlaming, Maria L.H., Anita van Esch, Els Wagenaar, et al.. (2009). Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo. Molecular Cancer Therapeutics. 8(12). 3350–3359. 54 indexed citations
13.
Waart, Dirk R. de, Maria L.H. Vlaming, Cindy Kunne, Alfred H. Schinkel, & Ronald P.J. Oude Elferink. (2009). Complex Pharmacokinetic Behavior of Ezetimibe Depends on Abcc2, Abcc3, and Abcg2. Drug Metabolism and Disposition. 37(8). 1698–1702. 35 indexed citations
14.
Lagas, Jurjen S., Maria L.H. Vlaming, & Alfred H. Schinkel. (2009). Pharmacokinetic Assessment of Multiple ATP-binding Cassette Transporters: The Power of Combination Knockout Mice. Molecular Interventions. 9(3). 136–145. 43 indexed citations
15.
Vlaming, Maria L.H., Anita van Esch, Els Wagenaar, et al.. (2008). Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate. Clinical Cancer Research. 14(24). 8152–8160. 48 indexed citations
16.
Vlaming, Maria L.H., Jurjen S. Lagas, & Alfred H. Schinkel. (2008). Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice. Advanced Drug Delivery Reviews. 61(1). 14–25. 175 indexed citations
17.
18.
Wetering, Koen van de, Noam Zelcer, Annemieke Kuil, et al.. (2007). Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides. Molecular Pharmacology. 72(2). 387–394. 82 indexed citations
19.
Jonker, Johan W., Maria L.H. Vlaming, Torsten Plösch, et al.. (2007). Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX. American Journal of Physiology-Cell Physiology. 292(6). C2204–C2212. 26 indexed citations
20.
Vlaming, Maria L.H., Karin Mohrmann, Els Wagenaar, et al.. (2006). Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 318(1). 319–327. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Köck Breakdown of academic impact, for papers by Sierk Haenisch Breakdown of academic impact, for papers by Pauline Breedveld Breakdown of academic impact, for papers by Yoshitane Nozaki Breakdown of academic impact, for papers by Maya K. Leabman Breakdown of academic impact, for papers by Kelly Bleasby Breakdown of academic impact, for papers by Janny G.P. Peters Breakdown of academic impact, for papers by Cornelia M.M. van der Kruijssen Breakdown of academic impact, for papers by Marie V. St–Pierre Breakdown of academic impact, for papers by Cindy Q. Xia
Rankless by CCL
2026